Author:
Lin Sen,Xie Peiling,Luo Mengmeng,Li Qing,Li Ling,Zhang Jinzhao,Zheng Qinxiang,Chen Hao,Nan Kaihui
Publisher
Springer Science and Business Media LLC
Subject
Electrical and Electronic Engineering,General Materials Science,Condensed Matter Physics,Atomic and Molecular Physics, and Optics
Reference62 articles.
1. Kutanzi, K. R.; Yurchenko, O. V.; Beland, F. A.; Checkhun, V. F.; Pogribny, I. P. MicroRNA-mediated drug resistance in breast cancer. Clin. Epigenetics 2011, 2, 171–185.
2. Santos, S. A.; Paulo, A. Small molecule inhibitors of multidrug resistance gene (MDR1) expression: Preclinical evaluation and mechanisms of action. Curr. Cancer Drug Tar. 2013, 13, 814–828.
3. Singh, P.; Paul, K.; Holzer, W. Multi drug resistance: An obstacle to the successful chemotherapy of cancer—its mechanism and remedies via MDR modulators. Natl. Acad. Sci. Lett. 2005, 28, 365–372.
4. Toppmeyer, D.; Seidman, A. D.; Pollak, M.; Russell, C.; Tkaczuk, K.; Verma, S.; Overmoyer, B.; Garg, V.; Ette, E.; Harding, M. W. et al. Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel. Clin. Cancer Res. 2002, 8, 670–678.
5. Burkhart, C. A.; Watt, F.; Murray, J.; Pajic, M.; Prokvolit, A.; Xue, C. Y.; Flemming, C.; Smith, J.; Purmal, A.; Isachenko, N. et al. Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma. Cancer Res. 2009, 69, 6573–6580.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献